IvelinRadkov/iStock via Getty Images
Avidity Biosciences (NASDAQ:RNA) has announced new data from its clinical trials evaluating the experimental treatment del-zota for Duchenne muscular dystrophy.
After one year of continuous treatment, participants showed not only a halt in disease progression, but also measurable improvements compared to their
The Indian IT sector is under scrutiny as the earnings season kicks off. ET Now recently spoke with market expert...
Seeking Alpha's Disclaimer: The earnings call insights are compilations of earnings call transcripts and other content available on the Seeking...
Mumbai: Soaring gold prices have not deterred central banks from purchasing the precious metal as they resumed shopping in August,...
This year, Fortune’s Asia team is highlighting several women leaders who are showing influence and power beyond the corporate boardroom. ...
As the Premier League’s Chelsea was on its way to a shutout victory at the Club World Cup final in July, President Donald...
A lot is riding on the AI boom, and it isn’t just the stock market surge. AI is being touted...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
